Parkside Financial Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.05K | Buy |
201
+16
| +9% | +$515 | ﹤0.01% | 1761 |
|
|
2025
Q4 | $5.77K | Sell |
185
-10,293
| -98% | -$254K | ﹤0.01% | 1757 |
|
|
2025
Q3 | $212K | Buy |
10,478
+22
| +0.2% | +$386 | 0.02% | 428 |
|
|
2025
Q2 | $175K | Sell |
10,456
-36
| -0.3% | -$581 | 0.02% | 462 |
|
|
2025
Q1 | $161K | Buy |
10,492
+134
| +1% | +$2.39K | 0.02% | 431 |
|
|
2024
Q4 | $228K | Hold |
10,358
| – | – | 0.03% | 356 |
|
|
2024
Q3 | $187K | Hold |
10,358
| – | – | 0.03% | 380 |
|
|
2024
Q2 | $168K | Hold |
10,358
| – | – | 0.03% | 388 |
|
|
2024
Q1 | $146K | Sell |
10,358
-500
| -5% | -$6.3K | 0.02% | 417 |
|
|
2023
Q4 | $113K | Buy |
10,858
+65
| +0.6% | +$607 | 0.02% | 445 |
|
|
2023
Q3 | $110K | Hold |
10,793
| – | – | 0.03% | 389 |
|
|
2023
Q2 | $81.3K | Hold |
10,793
| – | – | 0.02% | 468 |
|
|
2023
Q1 | $95.5K | Hold |
10,793
| – | – | 0.03% | 404 |
|
|
2022
Q4 | $98.4K | Buy |
10,793
+10,293
| +2,059% | +$89.8K | 0.03% | 389 |
|
|
2022
Q3 | $4K | Sell |
500
-500
| -50% | -$4.42K | ﹤0.01% | 1341 |
|
|
2022
Q2 | $8K | Buy |
1,000
+500
| +100% | +$4.36K | ﹤0.01% | 1081 |
|
|
2022
Q1 | $5K | Hold |
500
| – | – | ﹤0.01% | 1322 |
|
|
2021
Q4 | $4K | Hold |
500
| – | – | ﹤0.01% | 1428 |
|
|
2021
Q3 | $5K | Hold |
500
| – | – | ﹤0.01% | 1279 |
|
|
2021
Q2 | $5K | Hold |
500
| – | – | ﹤0.01% | 1257 |
|
|
2021
Q1 | $6K | Hold |
500
| – | – | ﹤0.01% | 1156 |
|
|
2020
Q4 | $5K | Sell |
500
-2,000
| -80% | -$19.2K | ﹤0.01% | 1133 |
|
|
2020
Q3 | $23K | Hold |
2,500
| – | – | 0.01% | 611 |
|
|
2020
Q2 | $31K | Hold |
2,500
| – | – | 0.01% | 529 |
|
|
2020
Q1 | $22K | Hold |
2,500
| – | – | 0.01% | 550 |
|
|
2019
Q4 | $25K | Buy |
2,500
+2,000
| +400% | +$17.9K | 0.01% | 601 |
|
|
2019
Q3 | $3K | Hold |
500
| – | – | ﹤0.01% | 1082 |
|
|
2019
Q2 | $5K | Hold |
500
| – | – | ﹤0.01% | 976 |
|
|
2019
Q1 | $8K | Hold |
500
| – | – | ﹤0.01% | 847 |
|
|
2018
Q4 | $8K | Hold |
500
| – | – | ﹤0.01% | 813 |
|
|
2018
Q3 | $11K | Buy |
+500
| New | +$11.6K | ﹤0.01% | 751 |
|
|
2017
Q1 | – | Sell |
-55
| Closed | -$2K | – | 1511 |
|
|
2016
Q4 | $2K | Sell |
55
-100
| -65% | -$3.99K | ﹤0.01% | 985 |
|
|
2016
Q3 | $8K | Sell |
155
-48
| -24% | -$2.5K | ﹤0.01% | 775 |
|
|
2016
Q2 | $10K | Buy |
203
+100
| +97% | +$5.32K | ﹤0.01% | 692 |
|
|
2016
Q1 | $6K | Buy |
103
+10
| +11% | +$587 | ﹤0.01% | 753 |
|
|
2015
Q4 | $6K | Sell |
93
-18
| -16% | -$1.11K | ﹤0.01% | 753 |
|
|
2015
Q3 | $6K | Buy |
+111
| New | +$7.2K | ﹤0.01% | 759 |
|
Other funds holding TEVA
HIIFS
PF
MMH
CI
MIFH
LIM
Parkside Financial Bank & Trust's TEVA Position: Q1 2026 in Review
Parkside Financial Bank & Trust increased its Teva Pharmaceuticals (TEVA) stake by 8.6% in Q1 2026, buying an estimated $515 and bringing the position to 201 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1761.
Parkside Financial Bank & Trust first reported a position in TEVA in Q3 2015 and has held it in 37 quarters since. The position peaked at $228K in Q4 2024. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.
- Parkside Financial Bank & Trust held 201 shares of Teva Pharmaceuticals worth $6.05K as of Q1 2026.
- Parkside Financial Bank & Trust bought 16 Teva Pharmaceuticals shares in Q1 2026, an estimated $515.
- Teva Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1761 holding.
- Parkside Financial Bank & Trust first reported a position in Teva Pharmaceuticals in Q3 2015 and has held it in 37 quarters since.
- Parkside Financial Bank & Trust's Teva Pharmaceuticals position peaked at $228K in Q4 2024.
- 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.